Trial intelligence / Profile preview

Compound omeprazole dry suspension for duodenal ulcer

ChiCTR-IPR-15007298Phase 4Recruiting

Sponsor
Third Xiangya Hospital, Central South University
Start
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of omeprazole in duodenal ulcer (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoint: Ulcer healing efficacy rate under gastroscopy. Started Nov 2015; status: recruiting.

02

Drugs

omeprazole
03

Conditions

duodenal ulcer

Beyond the preview

Go deeper on ChiCTR-IPR-15007298.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-15007298.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call